290 related articles for article (PubMed ID: 21926415)
1. A set of miRNAs that involve in the pathways of drug resistance and leukemic stem-cell differentiation is associated with the risk of relapse and glucocorticoid response in childhood ALL.
Han BW; Feng DD; Li ZG; Luo XQ; Zhang H; Li XJ; Zhang XJ; Zheng LL; Zeng CW; Lin KY; Zhang P; Xu L; Chen YQ
Hum Mol Genet; 2011 Dec; 20(24):4903-15. PubMed ID: 21926415
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide identification of microRNA signatures associated with stem/progenitor cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Valiollahi E; Ribera JM; Genescà E; Behravan J
Mol Biol Rep; 2019 Feb; 46(1):1295-1306. PubMed ID: 30712246
[TBL] [Abstract][Full Text] [Related]
3. Integrative computational in-depth analysis of dysregulated miRNA-mRNA interactions in drug-resistant pediatric acute lymphoblastic leukemia cells: an attempt to obtain new potential gene-miRNA pathways involved in response to treatment.
Mesrian Tanha H; Mojtabavi Naeini M; Rahgozar S; Moafi A; Honardoost MA
Tumour Biol; 2016 Jun; 37(6):7861-72. PubMed ID: 26700663
[TBL] [Abstract][Full Text] [Related]
4. MiR-124 contributes to glucocorticoid resistance in acute lymphoblastic leukemia by promoting proliferation, inhibiting apoptosis and targeting the glucocorticoid receptor.
Liang YN; Tang YL; Ke ZY; Chen YQ; Luo XQ; Zhang H; Huang LB
J Steroid Biochem Mol Biol; 2017 Sep; 172():62-68. PubMed ID: 28578002
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide analysis of small RNA and novel MicroRNA discovery in human acute lymphoblastic leukemia based on extensive sequencing approach.
Zhang H; Yang JH; Zheng YS; Zhang P; Chen X; Wu J; Xu L; Luo XQ; Ke ZY; Zhou H; Qu LH; Chen YQ
PLoS One; 2009 Sep; 4(9):e6849. PubMed ID: 19724645
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression profiles discriminate childhood T- from B-acute lymphoblastic leukemia.
Almeida RS; Costa E Silva M; Coutinho LL; Garcia Gomes R; Pedrosa F; Massaro JD; Donadi EA; Lucena-Silva N
Hematol Oncol; 2019 Feb; 37(1):103-112. PubMed ID: 30393877
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
8. Myeloid-derived suppressor cells and regulatory T cells share common immunoregulatory pathways-related microRNAs that are dysregulated by acute lymphoblastic leukemia and chemotherapy.
Labib Salem M; Zidan AA; Ezz El-Din El-Naggar R; Attia Saad M; El-Shanshory M; Bakry U; Zidan M
Hum Immunol; 2021 Jan; 82(1):36-45. PubMed ID: 33162185
[TBL] [Abstract][Full Text] [Related]
9. The Role of miRNAs in Childhood Acute Lymphoblastic Leukemia Relapse and the Associated Molecular Mechanisms.
Barrios-Palacios D; Organista-Nava J; Balandrán JC; Alarcón-Romero LDC; Zubillaga-Guerrero MI; Illades-Aguiar B; Rivas-Alarcón AA; Diaz-Lucas JJ; Gómez-Gómez Y; Leyva-Vázquez MA
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203290
[TBL] [Abstract][Full Text] [Related]
10. Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia.
Amankwah EK; Devidas M; Teachey DT; Rabin KR; Brown PA
Anticancer Res; 2020 Jun; 40(6):3147-3153. PubMed ID: 32487609
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs expression signatures are associated with lineage and survival in acute leukemias.
Wang Y; Li Z; He C; Wang D; Yuan X; Chen J; Jin J
Blood Cells Mol Dis; 2010 Mar; 44(3):191-7. PubMed ID: 20110180
[TBL] [Abstract][Full Text] [Related]
13. MiR-125b, miR-100 and miR-99a co-regulate vincristine resistance in childhood acute lymphoblastic leukemia.
Akbari Moqadam F; Lange-Turenhout EA; Ariës IM; Pieters R; den Boer ML
Leuk Res; 2013 Oct; 37(10):1315-21. PubMed ID: 23915977
[TBL] [Abstract][Full Text] [Related]
14. Deregulated expression of miR-29a-3p, miR-494-3p and miR-660-5p affects sensitivity to tyrosine kinase inhibitors in CML leukemic stem cells.
Salati S; Salvestrini V; Carretta C; Genovese E; Rontauroli S; Zini R; Rossi C; Ruberti S; Bianchi E; Barbieri G; Curti A; Castagnetti F; Gugliotta G; Rosti G; Bergamaschi M; Tafuri A; Tagliafico E; Lemoli R; Manfredini R
Oncotarget; 2017 Jul; 8(30):49451-49469. PubMed ID: 28533480
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
16. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
[TBL] [Abstract][Full Text] [Related]
17. A novel mutation in the miR-128b gene reduces miRNA processing and leads to glucocorticoid resistance of MLL-AF4 acute lymphocytic leukemia cells.
Kotani A; Ha D; Schotte D; den Boer ML; Armstrong SA; Lodish HF
Cell Cycle; 2010 Mar; 9(6):1037-42. PubMed ID: 20237425
[TBL] [Abstract][Full Text] [Related]
18. miRNA-seq analysis of human vertebrae provides insight into the mechanism underlying GIOP.
Ren H; Yu X; Shen G; Zhang Z; Shang Q; Zhao W; Huang J; Yu P; Zhan M; Lu Y; Liang Z; Tang J; Liang D; Yao Z; Yang Z; Jiang X
Bone; 2019 Mar; 120():371-386. PubMed ID: 30503955
[TBL] [Abstract][Full Text] [Related]
19. Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses.
Szczepanek J; Styczyński J; Haus O; Tretyn A; Wysocki M
Arch Immunol Ther Exp (Warsz); 2011 Feb; 59(1):61-8. PubMed ID: 21246408
[TBL] [Abstract][Full Text] [Related]
20. Mutations and deletions of the TP53 gene predict nonresponse to treatment and poor outcome in first relapse of childhood acute lymphoblastic leukemia.
Hof J; Krentz S; van Schewick C; Körner G; Shalapour S; Rhein P; Karawajew L; Ludwig WD; Seeger K; Henze G; von Stackelberg A; Hagemeier C; Eckert C; Kirschner-Schwabe R
J Clin Oncol; 2011 Aug; 29(23):3185-93. PubMed ID: 21747090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
